Choline PET/computed tomographic (CT) imaging represents the most diffused PET imaging techniques to investigate patients with prostate cancer (PCa). It may show the site of tumor recurrence in a single step examination, earlier than other conventional imaging techniques. In this context, the availability of a diagnostic test capable of differentiating between potentially curable local recurrence and metastatic disease implying palliative approaches may play an important role in those patients in whom targeted therapies could be performed according to choline PET/CT results. This review analyzes the value of choline PET/CT imaging in the evaluation of treatment of patients with PCa.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cpet.2015.05.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!